The non-toxic concentration of the FAG against RAW 264.7 murine macrophage cells exerted promising molecular modulation of the EGFR/Akt/PI3K signaling pathway, as summarized in Figure 8, which prompted us to estimate the anti-cancer activity of this new compound in the future. The gene discussed is AKT1; the disease is cancer.